Growth Hormone (GH) Treatment Decreases Plasma Kisspeptin Levels in GH-Deficient Adults with Prader–Willi Syndrome

Growth Hormone (GH) Treatment Decreases Plasma Kisspeptin Levels in GH-Deficient Adults with Prader–Willi Syndrome

Obesity and growth hormone (GH)-deficiency are consistent features of Prader–Willi syndrome (PWS). Centrally, kisspeptin is involved in regulating reproductive function and can stimulate hypothalamic hormones such as GH. Peripherally, kisspeptin signaling influences energy and metabolic status. We e...

Full description

Bibliographic Details
Main Authors: Olga Giménez-Palop, Laia Casamitjana, Raquel Corripio, Susanna Esteba-Castillo, Rocío Pareja, Néstor Albiñana, Mercedes Rigla, Assumpta Caixàs
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Journal of Clinical Medicine
Subjects:
Prader–Willi Syndrome
kisspeptin
leptin
growth hormone deficiency
Online Access:https://www.mdpi.com/2077-0383/10/14/3054

Internet

https://www.mdpi.com/2077-0383/10/14/3054

Similar Items